Metis Global Partners LLC Sells 1,318 Shares of Cigna Group $CI

Metis Global Partners LLC trimmed its holdings in Cigna Group (NYSE:CI) by 9.9% in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 12,044 shares of the health services provider’s stock after selling 1,318 shares during the quarter. Metis Global Partners LLC’s holdings in Cigna Group were worth $3,982,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in CI. Financial Network Wealth Advisors LLC lifted its holdings in shares of Cigna Group by 26.8% during the 1st quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock valued at $53,000 after buying an additional 34 shares during the period. Central Pacific Bank Trust Division lifted its holdings in Cigna Group by 1.0% in the second quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock valued at $1,137,000 after acquiring an additional 35 shares during the period. HBK Sorce Advisory LLC lifted its holdings in Cigna Group by 3.1% in the second quarter. HBK Sorce Advisory LLC now owns 1,263 shares of the health services provider’s stock valued at $418,000 after acquiring an additional 38 shares during the period. Legacy Financial Advisors Inc. boosted its position in Cigna Group by 2.9% in the first quarter. Legacy Financial Advisors Inc. now owns 1,400 shares of the health services provider’s stock worth $461,000 after purchasing an additional 39 shares during the last quarter. Finally, Samalin Investment Counsel LLC grew its stake in shares of Cigna Group by 2.2% during the 1st quarter. Samalin Investment Counsel LLC now owns 1,792 shares of the health services provider’s stock valued at $590,000 after purchasing an additional 39 shares during the period. Institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. This represents a 9.49% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David Cordani purchased 4,134 shares of Cigna Group stock in a transaction that occurred on Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the transaction, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. The trade was a 2.69% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the topic of several recent research reports. Guggenheim lowered their price objective on shares of Cigna Group from $350.00 to $309.00 in a research note on Friday, October 31st. Morgan Stanley reiterated an “overweight” rating and issued a $355.00 price target on shares of Cigna Group in a research report on Friday, October 31st. Zacks Research downgraded shares of Cigna Group from a “hold” rating to a “strong sell” rating in a research report on Monday, November 3rd. Wells Fargo & Company decreased their target price on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday. Finally, Robert W. Baird set a $372.00 price target on Cigna Group in a report on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.73.

Cigna Group Stock Up 3.2%

NYSE CI opened at $264.54 on Friday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a market cap of $70.66 billion, a PE ratio of 14.44, a P/E/G ratio of 0.88 and a beta of 0.44. The stock’s 50 day moving average is $293.24 and its 200 day moving average is $303.54.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter last year, the business posted $7.51 earnings per share. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s payout ratio is 26.64%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.